Metraipolis › archive › dc_76077309f260
Follow-Up of 3-Year Luspatercept Treatment in a Transfused ß-Thalassemia Patient. Bone Marrow: An Undervalued Iron Store — Europe PMC PMID:41321748
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41321748
- DOI
- 10.1002/jha2.70193
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T05:35:36.033Z
- SHA-256 of the archived text
75596217aa71a3a6e6b3ba741d470d9d9faac220d54c0f522b09cbc4efed17d9- Stable URL of this page
https://metraipolis.com/documento/dc_76077309f260
How to cite
Follow-Up of 3-Year Luspatercept Treatment in a Transfused ß-Thalassemia Patient. Bone Marrow: An Undervalued Iron Store — Europe PMC PMID:41321748 — Europe PMC (en), https://europepmc.org/article/MED/41321748 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_76077309f260 (Metraipolis archive dc_76077309f260, sha256 75596217aa71a3a6e6b3ba741d470d9d9faac220d54c0f522b09cbc4efed17d9)
BibTeX
@misc{dc76077309f260,
title = {Follow-Up of 3-Year Luspatercept Treatment in a Transfused ß-Thalassemia Patient. Bone Marrow: An Undervalued Iron Store — Europe PMC PMID:41321748},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41321748},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_76077309f260; sha256 75596217aa71a3a6e6b3ba741d470d9d9faac220d54c0f522b09cbc4efed17d9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41321748. Agents can read the archived copy with the MCP tool read_document.